BioSpace News Archive

Deals

Veristat Strengthens Clinical Operations Capabilities with The Acquisition of Topstone Research

Expanding Its Clinical Operations and Biometrics Teams Dedicated to Emerging, Small and Mid-Sized Biopharma

October 1, 2018
·
3 min read
Genetown

Convergent Dental Announces The Next Generation of Solea®

New, Smaller Solea Cuts Faster, Smoother and 99.2% Anesthesia-Free

October 1, 2018
·
2 min read
Business

Nektar Therapeutics Strengthens Board of Directors with Appointment of Veteran Biotechnology Executive Karin Eastham

Nektar Therapeutics (Nasdaq: NKTR) today announced that it has appointed Karin Eastham as an independent director to its Board of Directors.

October 1, 2018
·
3 min read
Biotech Bay

Pulse Biosciences to Present at the 2018 Cantor Global Healthcare Conference

Pulse Biosciences, Inc. announced today that Darrin Uecker, President and Chief Executive Officer, is scheduled to present at the Cantor Global Healthcare Conference in New York at 4:00 p.m. Eastern Time on Wednesday, October 3rd, 2018.

October 1, 2018
·
1 min read
Business

Allergan to Report Third Quarter 2018 Earnings and Host Conference Call and Webcast

Allergan plc today announced that it intends to release third quarter 2018 financial results on Tuesday, October 30, 2018, prior to the open of U.S. financial markets.

October 1, 2018
·
2 min read
Genetown

bluebird bio to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology

bluebird bio, Inc. today announced that members of the management team will present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology, Wednesday, October 3, at 3:30 p.m. ET at the Lotte New York Palace, New York City.

October 1, 2018
·
3 min read
Genetown

BlueRock Therapeutics to Present at 2018 Cell & Gene Meeting on the Mesa

BlueRock Therapeutics, LP today announced its participation in the Cell & Gene Meeting on the Mesa, to be held Oct. 3-5 in La Jolla, Calif.

October 1, 2018
·
3 min read
Pharm Country

Actinium Launches Iomab-ACT Program Offering Its Targeted, Chemo-Free, Lymphodepletion Technology as a Universal Solution to CAR-T Product Developers

Iomab-ACT program provides a single dose, outpatient, targeted lymphodepletion technology with the potential to improve CAR-T access and outcomes

October 1, 2018
·
8 min read
Business

NGM Bio Appoints David J. Woodhouse, Ph.D. as Chief Executive Officer and Aetna Wun Trombley, Ph.D. as President and Chief Operating Officer

Suzanne Sawochka Hooper Joins NGM’s Board of Directors

October 1, 2018
·
5 min read
Business

IBSA Pharma Inc. to debut at 88th Annual Meeting of the American Thyroid Association

U.S. subsidiary of IBSA Group, a multinational pharmaceutical company, is now the sole distributor and promoter of Tirosint® (levothyroxine sodium) capsules

October 1, 2018
·
1 min read